| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PNAS..111.7319H |
| P356 | DOI | 10.1073/PNAS.1324151111 |
| P932 | PMC publication ID | 4034202 |
| P698 | PubMed publication ID | 24778216 |
| P5875 | ResearchGate publication ID | 261956558 |
| P50 | author | Xiaole Shirley Liu | Q22099294 |
| Gwo-Shu Mary Lee | Q114400728 | ||
| Chen-Lin Hsieh | Q114410601 | ||
| Myles Brown | Q30347463 | ||
| Philip W. Kantoff | Q42532150 | ||
| Christopher Sweeney | Q91690717 | ||
| Steven P Balk | Q96135363 | ||
| P2093 | author name string | Yiwen Chen | |
| Xiaodong Wang | |||
| Tiantian Li | |||
| Tong Sun | |||
| Teng Fei | |||
| Yanfei Gao | |||
| Shaoyong Chen | |||
| P2860 | cites work | A large fraction of extragenic RNA pol II transcription sites overlap enhancers | Q21145794 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression | Q24313269 | ||
| Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells | Q24541489 | ||
| Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs | Q24673619 | ||
| Long noncoding RNAs with enhancer-like function in human cells | Q29614328 | ||
| Widespread transcription at neuronal activity-regulated enhancers | Q29614330 | ||
| Androgen receptor in prostate cancer | Q29616454 | ||
| Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions | Q29617830 | ||
| Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer | Q33235187 | ||
| lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. | Q33666551 | ||
| Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer | Q33823702 | ||
| Long noncoding RNAs usher in a new era in the biology of enhancers | Q33938960 | ||
| Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA | Q34185076 | ||
| Integrative eQTL-based analyses reveal the biology of breast cancer risk loci | Q34194768 | ||
| eRNAs are required for p53-dependent enhancer activity and gene transcription | Q34319965 | ||
| Activating RNAs associate with Mediator to enhance chromatin architecture and transcription | Q34328232 | ||
| Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation | Q34348069 | ||
| Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade | Q34390313 | ||
| Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth | Q35048908 | ||
| Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression | Q35154249 | ||
| Mechanisms mediating androgen receptor reactivation after castration | Q35633454 | ||
| Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene | Q36569298 | ||
| eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci | Q37205802 | ||
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer | Q37305014 | ||
| Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. | Q37340291 | ||
| Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus | Q37681929 | ||
| Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif | Q39439753 | ||
| The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis | Q39538459 | ||
| Evolution of the androgen receptor pathway during progression of prostate cancer. | Q40278784 | ||
| Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays | Q40290928 | ||
| Enhancer transcripts mark active estrogen receptor binding sites | Q42597586 | ||
| Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer | Q83069324 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7319-7324 | |
| P577 | publication date | 2014-04-28 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation | |
| P478 | volume | 111 |
| Q89446370 | A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans |
| Q41691950 | A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer |
| Q58093179 | A novel testis-specific long noncoding RNA, Tesra, activates the Prss42/Tessp-2 gene during mouse spermatogenesis |
| Q34489580 | A novel virus-inducible enhancer of the interferon-β gene with tightly linked promoter and enhancer activities |
| Q97587320 | A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer |
| Q60907348 | Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming |
| Q46230467 | Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. |
| Q33574512 | Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer |
| Q41764330 | Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer |
| Q39170566 | Analgesic use in pregnancy and male reproductive development |
| Q47157738 | Analysis of primary microRNA loci from nascent transcriptomes reveals regulatory domains governed by chromatin architecture. |
| Q26796369 | Architectural and Functional Commonalities between Enhancers and Promoters |
| Q36561822 | Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription |
| Q59129029 | CARM1 methylates MED12 to regulate its RNA-binding ability |
| Q54983326 | Chromatin Landscape Distinguishes the Genomic Loci of Hundreds of Androgen-Receptor-Associated LincRNAs From the Loci of Non-associated LincRNAs. |
| Q38737169 | Chromatin loops and causality loops: the influence of RNA upon spatial nuclear architecture |
| Q92503341 | Chromatin-associated RNAs as facilitators of functional genomic interactions |
| Q39756300 | Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. |
| Q55419712 | Current Advances on the Important Roles of Enhancer RNAs in Gene Regulation and Cancer. |
| Q38843392 | Deciphering the function of non-coding RNAs in prostate cancer. |
| Q36936254 | Diverse regulatory interactions of long noncoding RNAs |
| Q93016720 | Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate |
| Q64060816 | Downregulation of Long Non-coding RNA Inhibits Gastric Cancer Cell Migration and Invasion Through Impairing Expression by Exerting Its Enhancer-Like Function |
| Q89947600 | Dynamic CpG methylation delineates subregions within super-enhancers selectively decommissioned at the exit from naive pluripotency |
| Q36010921 | Effect of Interaction between Chromatin Loops on Cell-to-Cell Variability in Gene Expression |
| Q49529316 | Emerging Roles of Transcriptional Enhancers In Chromatin Looping And Promoter-Proximal Pausing Of RNA Polymerase II. |
| Q49646234 | Emerging themes in neuronal activity-dependent gene expression |
| Q34292008 | Enhancer RNA facilitates NELF release from immediate early genes |
| Q36569927 | Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster |
| Q43208340 | Enhancer RNAs |
| Q90352728 | Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment |
| Q96230995 | Enhancer RNAs are an important regulatory layer of the epigenome |
| Q64063687 | Enhancer RNAs: Insights Into Their Biological Role |
| Q34624854 | Enhancer alterations in cancer: a source for a cell identity crisis |
| Q38394580 | Enhancer-associated RNAs as therapeutic targets |
| Q33613467 | Enhancers and chromatin structures: regulatory hubs in gene expression and diseases |
| Q34046402 | Enhancers as non-coding RNA transcription units: recent insights and future perspectives |
| Q34372573 | Epigenomics of macrophages |
| Q26825066 | Exploiting genomics and natural genetic variation to decode macrophage enhancers |
| Q91871661 | From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions |
| Q46261346 | Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease. |
| Q90403778 | Functions and properties of nuclear lncRNAs-from systematically mapping the interactomes of lncRNAs |
| Q52849456 | Gene activation by metazoan enhancers: Diverse mechanisms stimulate distinct steps of transcription. |
| Q40685674 | Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues |
| Q49599218 | Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization |
| Q26782959 | Genomic Views of Transcriptional Enhancers: Essential Determinants of Cellular Identity and Activity-Dependent Responses in the CNS |
| Q39376859 | Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets. |
| Q52671030 | HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. |
| Q37148610 | High-throughput functional comparison of promoter and enhancer activities |
| Q37070115 | Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery |
| Q39055780 | In the loop: how chromatin topology links genome structure to function in mechanisms underlying learning and memory |
| Q35031399 | Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs |
| Q52328749 | JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. |
| Q92438534 | Ligand dependent gene regulation by transient ERα clustered enhancers |
| Q38916666 | Ligand-dependent enhancer activation regulated by topoisomerase-I activity |
| Q36290458 | Long Noncoding RNA ADINR Regulates Adipogenesis by Transcriptionally Activating C/EBPα |
| Q52804324 | Long ncRNA A-ROD activates its target gene DKK1 at its release from chromatin. |
| Q36604464 | Long non-coding RNA regulation of reproduction and development |
| Q38239035 | Long non-coding RNAs in the regulation of the immune response |
| Q39267063 | Long noncoding RNA: a crosslink in biological regulatory network |
| Q28077492 | Long noncoding RNAs: pivotal regulators in acute myeloid leukemia |
| Q93333202 | Maximizing the Utility of Cancer Transcriptomic Data |
| Q92132380 | MyoD induced enhancer RNA interacts with hnRNPL to activate target gene transcription during myogenic differentiation |
| Q49606480 | Nanog Expression in Embryonic Stem Cells - An Ideal Model System to Dissect Enhancer Function |
| Q39362922 | Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation |
| Q91636811 | Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase |
| Q36971597 | Noncoding RNAs: Regulators of the Mammalian Transcription Machinery |
| Q91720878 | Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1 |
| Q35612095 | PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy |
| Q64882504 | Production of Spliced Long Noncoding RNAs Specifies Regions with Increased Enhancer Activity. |
| Q38850992 | R-loop: an emerging regulator of chromatin dynamics. |
| Q38721439 | RNA Binding to CBP Stimulates Histone Acetylation and Transcription |
| Q35378833 | RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene. |
| Q90747992 | RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation |
| Q90750142 | Regulatory functions of the Mediator kinases CDK8 and CDK19 |
| Q55057906 | Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9. |
| Q26765422 | Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer |
| Q50960691 | SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs. |
| Q38894128 | Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies. |
| Q92635822 | Sex Differences in the Epigenome: A Cause or Consequence of Sexual Differentiation of the Brain? |
| Q42291804 | Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription |
| Q90724394 | Sno-derived RNAs are prevalent molecular markers of cancer immunity |
| Q89837706 | Splicing of enhancer-associated lincRNAs contributes to enhancer activity |
| Q42053143 | Structural aspects of the inactive X chromosome |
| Q42111356 | Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes |
| Q57105900 | Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer |
| Q33563729 | TET2 binds the androgen receptor and loss is associated with prostate cancer |
| Q90216980 | Targeted Enhancer Activation by a Subunit of the Integrator Complex |
| Q89767289 | Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors |
| Q37522950 | The C/ebp-Atf response element (CARE) location reveals two distinct Atf4-dependent, elongation-mediated mechanisms for transcriptional induction of aminoacyl-tRNA synthetase genes in response to amino acid limitation. |
| Q36922262 | The Determinants of Directionality in Transcriptional Initiation |
| Q26849595 | The Mediator complex: a central integrator of transcription |
| Q38674130 | The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment |
| Q35903450 | The many faces of long noncoding RNAs |
| Q52430211 | The mediator complex in genomic and non-genomic signaling in cancer. |
| Q42702579 | The multidimensional mechanisms of long noncoding RNA function. |
| Q90495142 | The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and mRNA transcription in mouse melanoma and macrophage cell lines |
| Q41440879 | Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells |
| Q91610618 | Transcriptional control by enhancers and enhancer RNAs |
| Q39329012 | Transcriptional enhancers: Transcription, function and flexibility. |
| Q90597918 | Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer |
| Q41678024 | Transcriptional landscape of the human cell cycle. |
| Q33898591 | Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis |
| Q47824199 | eRNA binding produces tailored CBP activity profiles to regulate gene expression. |
Search more.